Xometry, Inc.
For the period ended Sep 30, 2025. Filed Nov 4, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 4, 2025
XMTR$119.31-1.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited)
Condensed Consolidated Statements of Changes in Stockholders’Equity
Three months ended September 30, 2025 and 2024
| Class A - Common Stock · Class B - Common Stock · Additional Paid-In · Treasury Stock · Accumulated Other Comprehensive · Accumulated · Total Stockholders’ · Noncontrolling · Total | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | Capital | Shares | Amount | Income | Deficit | Equity | Interest | Equity | |
| Balance, June 30, 2025 | 49,107,080 | $— | 1,475,311 | $— | $685,986 | 220,994 | $(8,080) | $4,281 | $(411,785) | $270,402 | $1,119 | $271,521 |
| Exercise of common stock options | 166,305 | — | — | — | 1,288 | — | — | — | — | 1,288 | — | 1,288 |
| Vesting of restricted stock units | 263,850 | — | — | — | — | — | — | — | — | — | — | — |
| Donated common stock | 20,133 | — | — | — | 950 | — | — | — | — | 950 | — | 950 |
| Stock-based compensation | — | — | — | — | 10,748 | — | — | — | — | 10,748 | — | 10,748 |
| Comprehensive loss | ||||||||||||
| Foreign currency translation | — | — | — | — | — | — | — | 173 | — | 173 | 7 | 180 |
| Net loss | — | — | — | — | — | — | — | — | (11,597) | (11,597) | — | (11,597) |
| Total comprehensive loss | — | — | — | — | — | — | — | — | (11,597) | (11,424) | 7 | (11,417) |
| Balance, September 30, 2025 | 49,557,368 | $— | 1,475,311 | $— | $698,972 | 220,994 | $(8,080) | $4,454 | $(423,382) | $271,964 | $1,126 | $273,090 |
| Balance, June 30, 2024 | 46,322,810 | $— | 2,676,154 | $— | $665,555 | — | $— | $464 | $(350,185) | $315,834 | $1,150 | $316,984 |
| Exercise of common stock options | 277,829 | — | — | — | 1,420 | — | — | — | — | 1,420 | — | 1,420 |
| Vesting of restricted stock units | 148,029 | — | — | — | — | — | — | — | — | — | — | — |
| Donated common stock | 20,133 | — | — | — | 406 | — | — | — | — | 406 | — | 406 |
| Stock-based compensation | — | — | — | — | 6,954 | — | — | — | — | 6,954 | — | 6,954 |
| Comprehensive loss | ||||||||||||
| Foreign currency translation | — | — | — | — | — | — | — | 818 | — | 818 | (23) | 795 |
| Net loss | — | — | — | — | — | — | — | — | (10,199) | (10,199) | — | (10,199) |
| Total comprehensive loss | — | — | — | — | — | — | — | — | (10,199) | (9,381) | (23) | (9,404) |
| Balance, September 30, 2024 | 46,768,801 | $— | 2,676,154 | $— | $674,335 | — | $— | $1,282 | $(360,384) | $315,233 | $1,127 | $316,360 |
Condensed Consolidated Statements of Changes in Stockholders’ Equity
Nine months ended September 30, 2025 and 2024
| Class A - Common Stock · Class B - Common Stock · Additional Paid-In · Treasury Stock · Accumulated Other Comprehensive · Accumulated · Total Stockholders’ · Noncontrolling · Total | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | Capital | Shares | Amount | (Loss) Income | Deficit | Equity | Interest | Equity | |
| Balance, December 31, 2024 | 48,289,274 | $— | 1,475,311 | $— | $685,054 | — | $— | $(328) | $(370,273) | $314,453 | $1,143 | $315,596 |
| Exercise of common stock options | 311,699 | — | — | — | 2,703 | — | — | — | — | 2,703 | — | 2,703 |
| Vesting of restricted stock units | 1,100,274 | — | — | — | — | — | — | — | — | — | — | — |
| Shares issued in business combination | 16,716 | — | — | — | 625 | — | — | — | — | 625 | — | 625 |
| Donated common stock | 60,399 | — | — | — | 2,080 | — | — | — | — | 2,080 | — | 2,080 |
| Purchase of capped calls | — | — | — | — | (17,475) | — | — | — | — | (17,475) | — | (17,475) |
| Purchase of treasury stock | (220,994) | — | — | — | — | 220,994 | (8,080) | — | — | (8,080) | — | (8,080) |
| Stock-based compensation | — | — | — | — | 25,985 | — | — | — | — | 25,985 | — | 25,985 |
| Comprehensive loss | ||||||||||||
| Foreign currency translation | — | — | — | — | — | — | — | 4,782 | — | 4,782 | (16) | 4,766 |
| Net loss | — | — | — | — | — | — | — | — | (53,109) | (53,109) | (1) | (53,110) |
| Total comprehensive loss | — | — | — | — | — | — | — | — | (53,109) | (48,327) | (17) | (48,344) |
| Balance, September 30, 2025 | 49,557,368 | $— | 1,475,311 | $— | $698,972 | 220,994 | $(8,080) | $4,454 | $(423,382) | $271,964 | $1,126 | $273,090 |
| Balance, December 31, 2023 | 45,489,379 | $— | 2,676,154 | $— | $648,317 | — | $— | $855 | $(319,872) | $329,300 | $1,119 | $330,419 |
| Exercise of common stock options | 502,981 | — | — | — | 3,215 | — | — | — | — | 3,215 | — | 3,215 |
| Vesting of restricted stock units | 642,833 | — | — | — | — | — | — | — | — | — | — | — |
| Exercise of warrants | 52,126 | — | — | — | — | — | — | — | — | — | — | — |
| Shares issued in business combination | 21,083 | — | — | — | 625 | — | — | — | — | 625 | — | 625 |
| Donated common stock | 60,399 | — | — | — | 1,063 | — | — | — | — | 1,063 | — | 1,063 |
| Stock-based compensation | — | — | — | — | 21,115 | — | — | — | — | 21,115 | — | 21,115 |
| Comprehensive loss | ||||||||||||
| Foreign currency translation | — | — | — | — | — | — | — | 427 | — | 427 | 3 | 430 |
| Net (loss) income | — | — | — | — | — | — | — | — | (40,512) | (40,512) | 5 | (40,507) |
| Total comprehensive (loss) income | — | — | — | — | — | — | — | — | (40,512) | (40,085) | 8 | (40,077) |
| Balance, September 30, 2024 | 46,768,801 | $— | 2,676,154 | $— | $674,335 | — | $— | $1,282 | $(360,384) | $315,233 | $1,127 | $316,360 |
Condensed Consolidated Statements of
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.